Literature DB >> 17192123

New syndromes in mushroom poisoning.

Philippe Saviuc1, Vincent Danel.   

Abstract

Several new mushroom poisoning syndromes have been described since the early 1990s. In these syndromes, the onset of symptoms generally occurs >6 hours after ingestion. Treatment is mainly supportive. The syndrome induced by Amanita smithiana/proxima consists of acute tubulopathy, which appears earlier and does not have the same poor prognosis as the orellanine-induced syndrome. It has been described since 1992 in the US and Canada with A. smithiana; in France, Spain and Italy with A. proxima; and in Japan with A. pseudoporphyria. The responsible toxin is probably 2-amino-4,5-hexadienoic acid. The erythromelalgia syndrome has been described as early as the late 19th century in Japan and South Korea with Clitocybe acromelalga, and since 1996 in France and then Italy with C. amoenolens. Responsible toxins are probably acromelic acids identified in both species. Several cases of massive rhabdomyolysis have been reported since 1993 in France and 2001 in Poland after ingestion of large amounts of an edible and, until then, valuable species called Tricholoma equestre. These cases of rhabdomyolysis are associated with respiratory and cardiac (myocarditis) complications leading to death. Rhabdomyolysis with an apparently different mechanism was described in Taiwan in 2001 with Russula subnigricans. Finally, cases of encephalopathy were observed twice after ingestion of Hapalopilus rutilans in Germany in 1992 and Pleurocybella porrigens in Japan in 2004, where a convulsive encephalopathy outbreak was reported in patients with history of chronic renal failure.

Entities:  

Mesh:

Year:  2006        PMID: 17192123     DOI: 10.2165/00139709-200625030-00004

Source DB:  PubMed          Journal:  Toxicol Rev        ISSN: 1176-2551


  16 in total

Review 1.  [Mass poisoning events].

Authors:  H Desel
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-12-18       Impact factor: 0.840

Review 2.  Mycetism: a review of the recent literature.

Authors:  Kimberlie A Graeme
Journal:  J Med Toxicol       Date:  2014-06

3.  Outbreak of fatal mushroom poisoning with Amanita franchetii and Ramaria rufescens.

Authors:  Liang Huang; Xue Lan Liu; Chun Shui Cao; Qing Ying
Journal:  BMJ Case Rep       Date:  2009-02-23

Review 4.  Mushroom Poisoning.

Authors:  Robert Wennig; Florian Eyer; Andreas Schaper; Thomas Zilker; Hilke Andresen-Streichert
Journal:  Dtsch Arztebl Int       Date:  2020-10-16       Impact factor: 5.594

Review 5.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

Review 6.  Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review.

Authors:  Patrick L West; Janet Lindgren; B Zane Horowitz
Journal:  J Med Toxicol       Date:  2009-03

7.  Clusters of sudden unexplained death associated with the mushroom, Trogia venenata, in rural Yunnan Province, China.

Authors:  Guo-Qing Shi; Wen-Li Huang; Jian Zhang; Hong Zhao; Tao Shen; Robert E Fontaine; Lin Yang; Su Zhao; Bu-Lai Lu; Yue-Bing Wang; Lin Ma; Zhao-Xiang Li; Yang Gao; Zhu-Liang Yang; Guang Zeng
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

8.  Muscarinic toxicity among family members after consumption of mushrooms.

Authors:  Peter George; Narasimha Hegde
Journal:  Toxicol Int       Date:  2013-01

9.  Acute hepatorenal failure in a patient following consumption of mushrooms: a case report.

Authors:  Farzad Rahmani; Hanieh Ebrahimi Bakhtavar; Atefeh Ghavidel
Journal:  Iran Red Crescent Med J       Date:  2015-03-30       Impact factor: 0.611

10.  Mycophilic or mycophobic? Legislation and guidelines on wild mushroom commerce reveal different consumption behaviour in European countries.

Authors:  Ursula Peintner; Stefanie Schwarz; Armin Mešić; Pierre-Arthur Moreau; Gabriel Moreno; Philippe Saviuc
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.